89 related articles for article (PubMed ID: 24815186)
1. Targeting eIF4GI translation initiation factor affords an attractive therapeutic strategy in multiple myeloma.
Attar-Schneider O; Drucker L; Zismanov V; Tartakover-Matalon S; Lishner M
Cell Signal; 2014 Sep; 26(9):1878-87. PubMed ID: 24815186
[TBL] [Abstract][Full Text] [Related]
2. Migration and epithelial-to-mesenchymal transition of lung cancer can be targeted via translation initiation factors eIF4E and eIF4GI.
Attar-Schneider O; Drucker L; Gottfried M
Lab Invest; 2016 Sep; 96(9):1004-15. PubMed ID: 27501049
[TBL] [Abstract][Full Text] [Related]
3. NAD(P)H quinone-oxydoreductase 1 protects eukaryotic translation initiation factor 4GI from degradation by the proteasome.
Alard A; Fabre B; Anesia R; Marboeuf C; Pierre P; Susini C; Bousquet C; Pyronnet S
Mol Cell Biol; 2010 Feb; 30(4):1097-105. PubMed ID: 20028737
[TBL] [Abstract][Full Text] [Related]
4. eIF4E and eIF4GI have distinct and differential imprints on multiple myeloma's proteome and signaling.
Attar-Schneider O; Pasmanik-Chor M; Tartakover-Matalon S; Drucker L; Lishner M
Oncotarget; 2015 Feb; 6(6):4315-29. PubMed ID: 25717031
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells secretomes' affect multiple myeloma translation initiation.
Marcus H; Attar-Schneider O; Dabbah M; Zismanov V; Tartakover-Matalon S; Lishner M; Drucker L
Cell Signal; 2016 Jun; 28(6):620-30. PubMed ID: 26976208
[TBL] [Abstract][Full Text] [Related]
6. Multiple myeloma and bone marrow mesenchymal stem cells' crosstalk: Effect on translation initiation.
Attar-Schneider O; Zismanov V; Dabbah M; Tartakover-Matalon S; Drucker L; Lishner M
Mol Carcinog; 2016 Sep; 55(9):1343-54. PubMed ID: 26293751
[TBL] [Abstract][Full Text] [Related]
7. Multiple myeloma cells promote migration of bone marrow mesenchymal stem cells by altering their translation initiation.
Dabbah M; Attar-Schneider O; Zismanov V; Tartakover Matalon S; Lishner M; Drucker L
J Leukoc Biol; 2016 Oct; 100(4):761-770. PubMed ID: 27272311
[TBL] [Abstract][Full Text] [Related]
8. Specific isoforms of translation initiation factor 4GI show differences in translational activity.
Coldwell MJ; Morley SJ
Mol Cell Biol; 2006 Nov; 26(22):8448-60. PubMed ID: 16982693
[TBL] [Abstract][Full Text] [Related]
9. 4EGI-1 represses cap-dependent translation and regulates genome-wide translation in malignant pleural mesothelioma.
De A; Jacobson BA; Peterson MS; Jay-Dixon J; Kratzke MG; Sadiq AA; Patel MR; Kratzke RA
Invest New Drugs; 2018 Apr; 36(2):217-229. PubMed ID: 29116477
[TBL] [Abstract][Full Text] [Related]
10. Bevacizumab attenuates major signaling cascades and eIF4E translation initiation factor in multiple myeloma cells.
Attar-Schneider O; Drucker L; Zismanov V; Tartakover-Matalon S; Rashid G; Lishner M
Lab Invest; 2012 Feb; 92(2):178-90. PubMed ID: 22083671
[TBL] [Abstract][Full Text] [Related]
11. The cap-translation inhibitor 4EGI-1 induces apoptosis in multiple myeloma through Noxa induction.
Descamps G; Gomez-Bougie P; Tamburini J; Green A; Bouscary D; Maïga S; Moreau P; Le Gouill S; Pellat-Deceunynck C; Amiot M
Br J Cancer; 2012 May; 106(10):1660-7. PubMed ID: 22510748
[TBL] [Abstract][Full Text] [Related]
12. Translation of mRNAs from vesicular stomatitis virus and vaccinia virus is differentially blocked in cells with depletion of eIF4GI and/or eIF4GII.
Welnowska E; Castelló A; Moral P; Carrasco L
J Mol Biol; 2009 Dec; 394(3):506-21. PubMed ID: 19769989
[TBL] [Abstract][Full Text] [Related]
13. Multiple myeloma proteostasis can be targeted via translation initiation factor eIF4E.
Zismanov V; Attar-Schneider O; Lishner M; Heffez Aizenfeld R; Tartakover Matalon S; Drucker L
Int J Oncol; 2015 Feb; 46(2):860-70. PubMed ID: 25422161
[TBL] [Abstract][Full Text] [Related]
14. Small-molecule inhibition of proteasome and silencing by vascular endothelial cell growth factor-specific siRNA induce additive antitumor activity in multiple myeloma.
Koldehoff M; Beelen DW; Elmaagacli AH
J Leukoc Biol; 2008 Aug; 84(2):561-76. PubMed ID: 18458152
[TBL] [Abstract][Full Text] [Related]
15. Elevated Translation Initiation Factor eIF4E Is an Attractive Therapeutic Target in Multiple Myeloma.
Li S; Fu J; Lu C; Mapara MY; Raza S; Hengst U; Lentzsch S
Mol Cancer Ther; 2016 Apr; 15(4):711-9. PubMed ID: 26939700
[TBL] [Abstract][Full Text] [Related]
16. Rotavirus Nonstructural Protein NSP3 is not required for viral protein synthesis.
Montero H; Arias CF; Lopez S
J Virol; 2006 Sep; 80(18):9031-8. PubMed ID: 16940515
[TBL] [Abstract][Full Text] [Related]
17. Cleavage of eukaryotic translation initiation factor 4GII correlates with translation inhibition during apoptosis.
Marissen WE; Gradi A; Sonenberg N; Lloyd RE
Cell Death Differ; 2000 Dec; 7(12):1234-43. PubMed ID: 11175261
[TBL] [Abstract][Full Text] [Related]
18. Equol, an isoflavone metabolite, regulates cancer cell viability and protein synthesis initiation via c-Myc and eIF4G.
de la Parra C; Borrero-Garcia LD; Cruz-Collazo A; Schneider RJ; Dharmawardhane S
J Biol Chem; 2015 Mar; 290(10):6047-57. PubMed ID: 25593313
[TBL] [Abstract][Full Text] [Related]
19. Regulation of translation factors eIF4GI and 4E-BP1 during recovery of protein synthesis from inhibition by p53.
Constantinou C; Clemens MJ
Cell Death Differ; 2007 Mar; 14(3):576-85. PubMed ID: 16990847
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of DEPTOR induces apoptosis, increases chemosensitivity to doxorubicin and suppresses autophagy in RPMI-8226 human multiple myeloma cells in vitro.
Zhang H; Chen J; Zeng Z; Que W; Zhou L
Int J Mol Med; 2013 May; 31(5):1127-34. PubMed ID: 23503641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
